NASDAQ$LTBR

Lightbridge Corp · Q4 2025 earnings

Q4 2025 earnings · · After market close

Briefing

Lightbridge Corporation ended 2025 with $201.9 million in cash as it advanced uranium-zirconium fuel development with Idaho National Laboratory.

Lightbridge is pre-revenue, focused on nuclear fuel technology. At December 31, 2025, cash and equivalents were $201.9 million versus $40.0 million a year ago after equity raises. The company co-extruded depleted and enriched uranium-zirconium samples with INL and began Advanced Test Reactor testing. Cash used in operating activities was $14.3 million for the year (+$4.8 million YoY) as R&D activity increased.

  • Cash $201.9M provides multi-year runway for fuel development.
  • INL collaboration progressed on uranium-zirconium extrusion and ATR testing.
  • Pre-revenue development-stage company targeting LWR and SMR markets.
  • Working capital ~$201.7M at year-end.

Headline financials

Total Revenue

$0.00

No prior period
EPS (adj)

-$0.80

No prior period
Working Capital

$202M

No prior period
R&D Expenses

$9.21M

No prior period
G&A Expenses

$14M

No prior period
Net ATM Proceeds

$176M

No prior period
Net Income

-$19.6M

No prior period
Operating Income

-$23.2M

No prior period
Cash & Equivalents

$202M

No prior period

Revenue & EPS history

Lightbridge Corp · Revenue · Quarterly

$0

Q4 2025

Forward guidance

Lightbridge does not issue revenue guidance; milestones center on fuel sample testing results, regulatory engagement, and partnership progress with utilities and national labs.

Tailwinds

  • Strong balance sheet to fund R&D and licensing pathway.
  • Tangible progress on fuel fabrication and irradiation testing.
  • Potential role in advanced fuel for existing and next-gen reactors.

Headwinds

  • No near-term product revenue; ongoing operating cash burn.
  • Long regulatory and commercial adoption timeline for new fuel.
  • Capital markets dependence for funding beyond current cash.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

+0.6%

Avg return

Earnings day

+0.1%

Avg return

5 days after

-4.7%

Avg return

30 days after

55%

16 / 29 earnings

Positive

+24.8%

Q3 2021

Best reaction

-25.5%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+14.7%+14.2%+1.0%
Q4 2025+0.7%-9.4%-22.4%
Q1 2025+14.6%+8.7%+49.5%
Q3 2024-25.5%-14.6%-32.7%
Q2 2024-9.0%-18.3%-22.7%
Q1 2024-3.6%-6.3%-3.6%
Q3 2023+5.7%+6.6%-21.1%
Q2 2023+7.4%+5.2%-31.4%
Q1 2023-11.3%-2.5%+8.8%
Q3 2022+3.4%+12.7%+17.5%
Q2 2022+9.8%+17.2%-1.9%
Q1 2022-18.5%+11.0%-13.2%
Q3 2021+24.8%+36.1%-15.9%
Q2 2021+3.5%-2.4%-4.2%
Q1 2021+15.2%+21.5%+43.7%
Q3 2020+1.8%+3.3%+35.4%
Q2 2020-14.1%-26.4%-47.1%
Q1 2020-0.3%-2.2%-19.5%
Q3 2019-0.2%-20.8%-37.8%
Q2 2019-1.4%-1.4%+4.3%
Q1 2019-7.8%+4.4%-22.2%
Q3 2018+1.1%-6.6%-17.6%
Q2 2018+1.1%-2.2%+11.1%
Q1 2018+1.8%-1.8%+2.7%
Q3 2017+0.0%-8.0%-10.7%
Q2 2017+3.6%-6.2%+3.6%
Q1 2017+0.8%+9.5%+72.2%
Q3 2016+0.0%-11.0%-26.0%
Q2 2016-0.3%-8.7%-37.1%
Q1 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro